Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Finasteride may negatively affect male fertility.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

About 15% of US Army personnel use hair products containing hormone or placenta, with higher usage among non-whites, females, and enlisted personnel.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Overweight smokers have worse hair loss.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Finasteride reduces alcohol withdrawal severity and anxiety in mice, but may increase withdrawal severity in some cases.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.